martes, 20 de marzo de 2018

National Nutrition Month® (see related guidelines) 8/8 | National Guideline Clearinghouse

Search | National Guideline Clearinghouse

ngc



  • GUIDELINE SUMMARY
  •  
  • NGC:010778
  •  
  • 2015 JUL 22

Dexamethasone intravitreal implant for treating diabetic macular oedema.

  • GUIDELINE SUMMARY
  •  
  • NGC:011056
  •  
  • 2016 JAN

IWGDF guidance on use of interventions to enhance the healing of chronic ulcers of the foot in diabetes.

  • GUIDELINE SUMMARY
  •  
  • NGC:010274
  •  
  • 1994 (REVISED 2013 SEP)

SOLUTIONS® wound care algorithm.

  • GUIDELINE SUMMARY
  •  
  • NGC:011127
  •  
  • 2017 JAN 3

Management of acute and recurrent gout: a clinical practice guideline from the American College of Physicians.

  • GUIDELINE SUMMARY
  •  
  • NGC:009588
  •  
  • 2013 FEB (REAFFIRMED 2015)

Clinical Pharmacogenetics Implementation Consortium guidelines for human leukocyte antigen-B genotype and allopurinol dosing.

  • GUIDELINE SUMMARY
  •  
  • NGC:009594
  •  
  • 2013 JAN

Clinical guideline: management of gastroparesis.

  • GUIDELINE SUMMARY
  •  
  • NGC:010720
  •  
  • 2015 FEB

Pharmacological management of obesity: an Endocrine Society clinical practice guideline.

  • GUIDELINE SUMMARY
  •  
  • NGC:010511
  •  
  • 2006 DEC (REVISED 2014)

VA/DoD clinical practice guideline for screening and management of overweight and obesity.

  • GUIDELINE SUMMARY
  •  
  • NGC:010323
  •  
  • 2014 MAR

Management of chronic kidney disease.

  • GUIDELINE SUMMARY
  •  
  • NGC:010696
  •  
  • 2015 APR 7

Recommendations for growth monitoring, and prevention and management of overweight and obesity in children and youth in primary care.

  • GUIDELINE SUMMARY
  •  
  • NGC:010781
  •  
  • 2004 (UPDATED 2015 AUG 26)

Type 1 diabetes in adults: diagnosis and management.

Prevention and management of obesity for adults.

  • GUIDELINE SUMMARY
  •  
  • NGC:010198
  •  
  • 1996 (REVISED 2014 MAR 18)

Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statement.


No hay comentarios: